Riskpilot← Back to searchSign inGet full accessInnovera AB
ABActiveOrg 5568835192Granitvägen 3General medical practice activities · NACE 8621Est. 20121 employees
Revenue 2025
SEK 663K
+333% vs 2024
EBITDA margin
-60.3%
-485% vs 2024
Equity ratio
-139.6%
Financial strength
Net profit 2025
SEK -402K
-487% vs 2024
| Revenue | SEK 663K | +333% |
| EBITDA | SEK -400K | -485% |
| Net profit | SEK -402K | -487% |
| Total assets | SEK 260K | -16% |
| Equity | SEK -363K | -1031% |
| Employees | 1 | — |
Legal name
Innovera AB
Org number
5568835192
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 februari 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Konsulttjänster inom bygg. Husbyggnation, renovering och ombyggnad. Arbete med geoteknik och övriga markarbeten. Konstruktions- och energiberäkningar. Uthyrning av personal. Entreprenadverksamhet. Försäljning av varor inom bygg, anläggning, kontorsmaterial och sjukvårdsprodukter.
Address
Granitvägen 3
Phone
+46763089596
Email
davidclaesson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 382 | 391 | 0 | 153 | 663 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 87 | −37 | −26 | 104 | −400 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 87 | −37 | −26 | 104 | −400 |
| Net financials | — | −1 | −9 | — | −2 |
| Profit before tax | 87 | −38 | −35 | 104 | −402 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 87 | −38 | −35 | 104 | −402 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 149 | 239 | 175 | 308 | 260 |
| Equity | 8 | −30 | −64 | 39 | −363 |
| Long-term debt | 18 | 17 | 190 | 160 | 17 |
| Short-term debt | 123 | 252 | 50 | 109 | 606 |
| Total debt | 141 | 269 | 240 | 269 | 623 |
EBITDA margin
-60.3%
This company
15.8%
Market median
-482% vs market
20212025
Equity ratio
-139.6%
This company
38.2%
Market median
-465% vs market
20212025
Return on equity
-40200000.0%
This company
18.4%
Market median
-218478361% vs market
20212025
Net profit margin
-60.6%
This company
8.1%
Market median
-848% vs market
20212025
Asset turnover
2.55×
This company
1.12×
Market median
+128% vs market
20212025
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Innovera AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jessica Byrén Claesson | Deputy Board Member | 0 companies |
| David Fredrik Axel Byrén Claesson | Board of Directors | 0 companies |